Citation Impact
Citing Papers
Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection
2005
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Hypertonic saline improves myocardial blood flow during CPR, but is not enhanced further by the addition of hydroxy ethyl starch
2003
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Normal values for Doppler echocardiographic assessment of heart valve prostheses
2003
What is the “Optimal” follow-up schedule for ICD patients?
2005
Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study
2000
Quality‐of‐Life Six Months After CABG Surgery in Patients Randomized to ICD Versus No ICD Therapy: Findings from the CABG Patch Trial
1999
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
2009
Classification of atrial fibrillation
1998
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
2010
Effects of hypertonic saline on myocardial blood flow in a porcine model of prolonged cardiac arrest
2002
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
NA+‐ and K+‐channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres
2007
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Heart Rate Reduction by If-Channel Inhibition and its Potential Role in Heart Failure with Reduced and Preserved Ejection Fraction
2009
Thyroid Hormone and the Cardiovascular System
2001 Standout
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease)
2010
European Policy on Driving for Patients with Implantable Cardioverter Defibrillators
1996
Facilitating Transthoracic Cardioversion of Atrial Fibrillation with Ibutilide Pretreatment
1999
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid
2007
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Therapeutic effects of If blockade: Evidence and perspective
2006
Oxygen Uptake to Work Rate Relation Throughout Peak Exercise in Normal Subjects: Relevance for Rate Adaptive Pacemaker Programming
1999
If Inhibition with Ivabradine
2008
Diabetes and Atherosclerosis
2002 Standout
Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: A placebo-controlled study
1996
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Burden of valvular heart diseases: a population-based study
2006 Standout
A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation
2000
Accuracy of intraoperative transesophageal echocardiography for estimating the severity of functional mitral regurgitation
1995
Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study
2001
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Effects of afterload reduction on vena contracta width in mitral regurgitation
1998
Clinical Performance of the Implantable Cardioverter Defibrillator: Electrocardiographic Documentation of 101 Spontaneous Discharges
1991
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
2015 Standout
Enhanced Detection Criteria in Implantable Cardioverter-Defibrillators to Avoid Inappropriate Therapy
1996
Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine
2004
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
2006
Comparison of Vena Contracta Width by Multiplane Transesophageal Echocardiography With Quantitative Doppler Assessment of Mitral Regurgitation
1998
Quality of life in the Canadian Implantable Defibrillator Study (CIDS)
2002
Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy
2004
Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
2014
Influence of Hypertonic Saline Solution Infusion on Defibrillation Efficacy
1996
Comparison of the Effects of AV Nodal Ablation Versus AV Nodal Modification in Patients with Congestive Heart Failure and Uncontrolled Atrial Fibrillation
1998
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure☆
2008
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Clopidogrel Versus Dipyridamole in Addition to Aspirin in Reducing Embolization Detected With Ambulatory Transcranial Doppler
2011
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
2003 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial
2001
Assessment of Mitral Regurgitation Severity by Doppler Color Flow Mapping of the Vena Contracta
1997
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators
2001
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Quality of Life and Psychological Status of Patients With Implantable Cardioverter Defibrillators
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators
1998
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Effects of Amiodarone on the Thyroid*
2001
The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population
2007
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Heart rate slowing by If inhibition: therapeutic utility from clinical trials
2005
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Assessment of Severity of Aortic Regurgitation Using the Width of the Vena Contracta
2000
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
Works of M Manz being referenced
Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis
1989
Color-coded Doppler imaging of the vena contracta as a basis for quantification of pure mitral regurgitation
1994
Heart rate during exercise: What is the optimal goal of rate adaptive pacemaker therapy?
1994
Effects of Antiarrhythmic Drugs on Epicardial Defibrillation Energy Requirements and the Rate of Defibrillator Discharges
1993
Incidence of ICD Lead Related Complications During Long‐Term Follow‐Up: Comparison of Epicardial and Endocardial Electrode Systems
1995
Patient acceptance of implantable cardioverter defibrillator devices: Changing attitudes
1994
Effects of chronic amiodarone therapy on defibrillation threshold
1992
Direct Angiography of the Coronary Sinus: Impact on Left Posteroseptal Accessory Pathway Ablation
1996
A Single Intravenous Dose of Ivabradine, a Novel I<sub>f</sub> Inhibitor, Lowers Heart Rate but Does Not Depress Left Ventricular Function in Patients with Left Ventricular Dysfunction
2003
Complications of pacemaker-defibrillator devices: Diagnosis and management
1994
Patient Acceptance of the Implantable Cardioverter Defibrillator in Ventricular Tachyarrhythmias
1993
Heart rate to work rate relation throughout peak exercise in normal subjects as a guideline for rate-adaptive pacemaker programming
1995
Supraventricular tachycardia and pre-excitation syndromes: Pharmacological therapy
1993
Morphology of the Mitral Valve as Displayed by Multiplane Transesophageal Echocardiography
1994
Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia
1992
Surgical treatment of the Wolff-Parkinson-white syndrome--experiences in 120 patients
1993
Predictors of outcome in patients with implantable transvenous cardioverter defibrillators
1994
Myocardial and cerebral hemodynamics during tachyarrhythmia-induced hypotension in the rat.
1994
Intracranial Microembolic Signals in 500 Patients With Potential Cardiac or Carotid Embolic Source and in Normal Controls
1997
Combination of Antiarrhythmic Drugs
1991
Erroneous discharge from an implanted automatic defibrillator during supraventricular tachyarrhythmia induced ventricular fibrillation
1986
Echocardiographic profile of the normally functioning Omnicarbon valve.
1994